Hair loss

Hair loss telehealth programs combine prescription-grade oral and topical medicines with ongoing clinical follow-up. Providers pair finasteride, dutasteride, minoxidil, and supportive supplements to slow shedding and restart follicle activity.

This guide explains what each option does, how long results take, and how to check that a program is monitoring labs and side effects responsibly.

An intake visit documents shedding patterns, family history, medications, and blood pressure. Clinicians then prescribe oral therapy, topical blends, or compounded kits and ship them with refills. Follow-ups every 3–6 months adjust doses and add supportive treatments such as low-level light or microneedling referrals.

Ideal for adults with androgenetic alopecia, postpartum shedding, or traction loss who want medical-grade interventions without traveling to a dermatology clinic. Programs can be tailored for sensitive scalps and combine oral plus topical options when tolerated.

Finasteride and dutasteride reduce DHT and slow follicle miniaturization. Topical minoxidil improves blood flow locally. Oral minoxidil at low doses is gaining support for stubborn cases. Adding ketoconazole or spironolactone for women can further balance hormones.

Finasteride can cause decreased libido or mood changes in a small percentage of patients. Oral minoxidil may alter blood pressure or cause swelling. Telehealth teams should re-check vitals, review mental health, and pause treatment if concerning symptoms arise.